Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.
作者信息
Liu Zeming, Long Wei, Tu Mengqi, Chen Sichao, Huang Yihui, Wang Shipei, Zhou Wei, Chen Danyang, Zhou Ling, Wang Min, Wu Meng, Huang Qi, Xu Haibo, Zeng Wen, Guo Liang
机构信息
Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
出版信息
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.054. Epub 2020 Apr 11.
Abstract
摘要
相似文献
1
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.淋巴细胞亚群（CD4+、CD8+）计数反映感染的严重程度，并可预测新型冠状病毒肺炎患者的临床结局。
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.054. Epub 2020 Apr 11.
2
CD4+T, CD8+T counts and severe COVID-19: A meta-analysis.CD4+T、CD8+T细胞计数与重症新型冠状病毒肺炎：一项荟萃分析。
J Infect. 2020 Sep;81(3):e82-e84. doi: 10.1016/j.jinf.2020.06.036. Epub 2020 Jun 20.
3
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.新冠肺炎患者中受抑制的 T 细胞介导的免疫：来自中国武汉的临床回顾性研究。
J Infect. 2020 Jul;81(1):e51-e60. doi: 10.1016/j.jinf.2020.04.012. Epub 2020 Apr 18.
4
T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.外周血 T 细胞亚群计数可作为新型冠状病毒肺炎诊断和严重程度预测的鉴别生物标志物。
J Infect Dis. 2020 Jun 29;222(2):198-202. doi: 10.1093/infdis/jiaa252.
5
Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.基于细胞因子和淋巴细胞亚群组合的 SARS-CoV-2 感染预后预测模型。
J Clin Immunol. 2020 Oct;40(7):960-969. doi: 10.1007/s10875-020-00821-7. Epub 2020 Jul 13.
6
The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.淋巴细胞亚群在 COVID-19 患者中的特征和预测作用。
Int J Infect Dis. 2020 Oct;99:92-99. doi: 10.1016/j.ijid.2020.06.079. Epub 2020 Aug 3.
7
Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.新型冠状病毒肺炎患者淋巴细胞亚群计数的Meta 分析。
Cytometry A. 2020 Aug;97(8):772-776. doi: 10.1002/cyto.a.24172. Epub 2020 Jul 18.
8
The clinical course and its correlated immune status in COVID-19 pneumonia.新型冠状病毒肺炎的临床过程及其相关免疫状态。
J Clin Virol. 2020 Jun;127:104361. doi: 10.1016/j.jcv.2020.104361. Epub 2020 Apr 12.
9
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.新型冠状病毒肺炎外周血淋巴细胞亚群特征变化。
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
10
The laboratory tests and host immunity of COVID-19 patients with different severity of illness.不同疾病严重程度的 COVID-19 患者的实验室检测和宿主免疫。
JCI Insight. 2020 May 21;5(10):137799. doi: 10.1172/jci.insight.137799.
引用本文的文献
1
A Review of the Hematological Picture of Severe COVID-19 Infection.重症新型冠状病毒肺炎感染的血液学表现综述
Cureus. 2025 Feb 9;17(2):e78797. doi: 10.7759/cureus.78797. eCollection 2025 Feb.
2
T Cell Responses to BA.2.86 and JN.1 SARS-CoV-2 Variants in Elderly Subjects.老年受试者对BA.2.86和JN.1新型冠状病毒变种的T细胞反应
Vaccines (Basel). 2024 Dec 23;12(12):1451. doi: 10.3390/vaccines12121451.
3
The CD4 T cell-independent IgG response during persistent virus infection favors emergence of neutralization-escape variants.持续性病毒感染期间不依赖CD4 T细胞的IgG反应有利于中和逃逸变体的出现。
bioRxiv. 2024 Dec 23:2024.12.22.629980. doi: 10.1101/2024.12.22.629980.
4
Neutrophils in the Spotlight-An Analysis of Neutrophil Function and Phenotype in ARDS.聚焦中性粒细胞——急性呼吸窘迫综合征中中性粒细胞功能与表型分析
Int J Mol Sci. 2024 Nov 22;25(23):12547. doi: 10.3390/ijms252312547.
5
The causal role of immune cells in susceptibility and severity of COVID-19: A bidirectional Mendelian randomization study.免疫细胞在新冠病毒疾病易感性和严重程度中的因果作用：一项双向孟德尔随机化研究
J Intensive Med. 2024 Mar 21;4(4):537-538. doi: 10.1016/j.jointm.2024.02.001. eCollection 2024 Oct.
6
Miliary TB and COVID-19 Coinfection in a Patient With a History of Post-polycythemia Vera Myelofibrosis Treated With Ruxolitinib: A Case Report.一例接受鲁索替尼治疗的真性红细胞增多症后骨髓纤维化患者并发粟粒性肺结核和新型冠状病毒肺炎：病例报告
Cureus. 2024 Jul 3;16(7):e63791. doi: 10.7759/cureus.63791. eCollection 2024 Jul.
7
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.SARS-CoV-2 相关的淋巴细胞减少症：可能的机制和 CD147 的作用。
Cell Commun Signal. 2024 Jul 4;22(1):349. doi: 10.1186/s12964-024-01718-3.
8
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models.新型冠状病毒病的免疫生物学：来自动物模型的机制和治疗见解。
Zool Res. 2024 Jul 18;45(4):747-766. doi: 10.24272/j.issn.2095-8137.2024.062.
9
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.在 COVID-19 患者中，抗淋巴细胞 IgM 自身抗体驱动补体激活的流行情况。
Front Immunol. 2024 Apr 17;15:1352330. doi: 10.3389/fimmu.2024.1352330. eCollection 2024.
10
Histochemical Evidence for Reduced Immune Response in Nasal Mucosa of Patients with COVID-19.新冠病毒病患者鼻黏膜免疫反应降低的组织化学证据
Int J Mol Sci. 2024 Apr 17;25(8):4427. doi: 10.3390/ijms25084427.
本文引用的文献
1
Clinical progression of patients with COVID-19 in Shanghai, China.中国上海 COVID-19 患者的临床进展。
J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19.
2
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.重症急性呼吸综合征患者的血液学表现：回顾性分析
BMJ. 2003 Jun 21;326(7403):1358-62. doi: 10.1136/bmj.326.7403.1358.
3
Decreased CCR5 expression on CD4+ T cells of SIV-infected sooty mangabeys.感染SIV的乌黑白眉猴CD4+ T细胞上CCR5表达降低。
AIDS Res Hum Retroviruses. 2003 Mar;19(3):227-33. doi: 10.1089/088922203763315731.
4
Respiratory syncytial virus and other respiratory viruses.呼吸道合胞病毒及其他呼吸道病毒。
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S6-10; discussion S10-2. doi: 10.1097/01.inf.0000053880.92496.db.
5
Acute primary infection with cytomegalovirus (CMV) in kidney transplant recipients results in the appearance of a phenotypically aberrant CD8+ T cell population.肾移植受者巨细胞病毒（CMV）急性原发性感染会导致出现表型异常的CD8 + T细胞群体。
Microbiol Immunol. 2000;44(12):1011-7. doi: 10.1111/j.1348-0421.2000.tb02597.x.
Zotero 插件